Table 2.

Chi-square statistics comparing individual drugs per severity level between patient self-reported^a treatments and rheumatologist recommendations.

Treatment option	Expected rate of rheumatologist recommendation (%)	Disease severity	Chi-square (df)	P value	Reject the null hypothesis
NSAIDb	54	Mild	0.8 (1)	.36	No
Corticosteroids	23	Mild	0.2 (1)	.62	No
Antimalarials	32	Mild	8.8 (1)	.003	Yes
Immunosuppressive agents	9	Mild	0.2 (1)	.67	No
Belimumab	15	Mild	2.1 (1)	.15	No
Rituximab	12	Mild	7.4 (1)	.007	Yes
NSAID	25	Moderate	5.5 (1)	.02	Yes
Corticosteroids	41	Moderate	3.1 (1)	.08	No
Antimalarials	35	Moderate	4.5 (1)	.03	Yes
Immunosuppressive agents	34	Moderate	9.0 (1)	.003	Yes
Belimumab	35	Moderate	9.1 (1)	.003	Yes
Rituximab	23	Moderate	13.7 (1)	.002	Yes
NSAID	21	Severe	5.8 (1)	.02	Yes
Corticosteroids	36	Severe	0.1 (1)	.75	No
Antimalarials	33	Severe	0.7 (1)	.41	No
Immunosuppressive agents	56	Severe	1.1 (1)	.29	No
Belimumab	50	Severe	0.0 (1)	.99	No
Rituximab	65	Severe	1.3 (1)	.25	No
All treatment options by all disease severities	N/Ac	N/Ac	73.5 (1)	<.001	Yes

^aIn patients who were pregnant, trying to conceive, or recently pregnant.

^bNSAID: nonsteroidal anti-inflammatory drug.

^cN/A: not applicable.